Literature DB >> 15939839

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Ronald C Kessler1, Wai Tat Chiu, Olga Demler, Kathleen R Merikangas, Ellen E Walters.   

Abstract

BACKGROUND: Little is known about the general population prevalence or severity of DSM-IV mental disorders.
OBJECTIVE: To estimate 12-month prevalence, severity, and comorbidity of DSM-IV anxiety, mood, impulse control, and substance disorders in the recently completed US National Comorbidity Survey Replication. DESIGN AND
SETTING: Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using a fully structured diagnostic interview, the World Health Organization World Mental Health Survey Initiative version of the Composite International Diagnostic Interview. PARTICIPANTS: Nine thousand two hundred eighty-two English-speaking respondents 18 years and older. MAIN OUTCOME MEASURES: Twelve-month DSM-IV disorders.
RESULTS: Twelve-month prevalence estimates were anxiety, 18.1%; mood, 9.5%; impulse control, 8.9%; substance, 3.8%; and any disorder, 26.2%. Of 12-month cases, 22.3% were classified as serious; 37.3%, moderate; and 40.4%, mild. Fifty-five percent carried only a single diagnosis; 22%, 2 diagnoses; and 23%, 3 or more diagnoses. Latent class analysis detected 7 multivariate disorder classes, including 3 highly comorbid classes representing 7% of the population.
CONCLUSION: Although mental disorders are widespread, serious cases are concentrated among a relatively small proportion of cases with high comorbidity.

Entities:  

Mesh:

Year:  2005        PMID: 15939839      PMCID: PMC2847357          DOI: 10.1001/archpsyc.62.6.617

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  37 in total

1.  Psychopathology and attrition in the epidemiologic catchment area surveys.

Authors:  W W Eaton; J C Anthony; S Tepper; A Dryman
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

2.  Screening for psychosis in the general population with a self-report interview.

Authors:  W W Eaton; A Romanoski; J C Anthony; G Nestadt
Journal:  J Nerv Ment Dis       Date:  1991-11       Impact factor: 2.254

3.  Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study.

Authors:  H U Wittchen; C A Essau; D von Zerssen; J C Krieg; M Zaudig
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

4.  Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul.

Authors:  C K Lee; Y S Kwak; J Yamamoto; H Rhee; Y S Kim; J H Han; J O Choi; Y H Lee
Journal:  J Nerv Ment Dis       Date:  1990-04       Impact factor: 2.254

5.  Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule.

Authors:  H G Hwu; E K Yeh; L Y Chang
Journal:  Acta Psychiatr Scand       Date:  1989-02       Impact factor: 6.392

6.  Analyzing twin resemblance in multisymptom data: genetic applications of a latent class model for symptoms of conduct disorder in juvenile boys.

Authors:  L J Eaves; J L Silberg; J K Hewitt; M Rutter; J M Meyer; M C Neale; A Pickles
Journal:  Behav Genet       Date:  1993-01       Impact factor: 2.805

Review 7.  Advances in strategies for minimizing and adjusting for survey nonresponse.

Authors:  R C Kessler; R J Little; R M Groves
Journal:  Epidemiol Rev       Date:  1995       Impact factor: 6.222

8.  Christchurch Psychiatric Epidemiology Study, Part I: Methodology and lifetime prevalence for specific psychiatric disorders.

Authors:  J E Wells; J A Bushnell; A R Hornblow; P R Joyce; M A Oakley-Browne
Journal:  Aust N Z J Psychiatry       Date:  1989-09       Impact factor: 5.744

9.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

10.  Psychoactive drug use in a general population sample, Sweden: correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study.

Authors:  C Allgulander
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

View more
  2000 in total

1.  Perseverate or decenter? Differential effects of metacognition on the relationship between parasympathetic inflexibility and symptoms of depression in a multi-wave study.

Authors:  Jonathan P Stange; Jessica L Hamilton; David M Fresco; Lauren B Alloy
Journal:  Behav Res Ther       Date:  2017-07-17

2.  Assessing and Treating Child Anxiety in Schools.

Authors:  Matthew P Mychailyszyn; Rinad S Beidas; Courtney L Benjamin; Julie M Edmunds; Jennifer L Podell; Jeremy S Cohen; Philip C Kendall
Journal:  Psychol Sch       Date:  2011-01-11

3.  The potential research impact of patient reported outcomes on osteogenesis imperfecta.

Authors:  Catherine A Brownstein; Paul Wicks
Journal:  Clin Orthop Relat Res       Date:  2010-10       Impact factor: 4.176

4.  Factor Structure and Sensitivity to Change of the Recovery Assessment Scale.

Authors:  Salene M W Jones; Evette J Ludman
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

5.  Do More of Those in Misery Suffer from Poverty, Unemployment or Mental Illness?

Authors:  Sarah Flèche; Richard Layard
Journal:  Kyklos (Oxford)       Date:  2017-01-21

6.  Association between attention bias to threat and anxiety symptoms in children and adolescents.

Authors:  Rany Abend; Leone de Voogd; Elske Salemink; Reinout W Wiers; Koraly Pérez-Edgar; Amanda Fitzgerald; Lauren K White; Giovanni A Salum; Jie He; Wendy K Silverman; Jeremy W Pettit; Daniel S Pine; Yair Bar-Haim
Journal:  Depress Anxiety       Date:  2017-12-06       Impact factor: 6.505

7.  Test-retest & familial concordance of MDD symptoms.

Authors:  Ariela J E Kaiser; Carter J Funkhouser; Vijay A Mittal; Sebastian Walther; Stewart A Shankman
Journal:  Psychiatry Res       Date:  2020-07-20       Impact factor: 3.222

8.  Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Yasushi Yabuki; Ibuki Takahata; Kazuya Matsuo; Yuji Owada; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

9.  Feasibility and effectiveness of an automated telehealth intervention to improve illness self-management in people with serious psychiatric and medical disorders.

Authors:  Sarah I Pratt; Stephen J Bartels; Kim T Mueser; John A Naslund; Rosemarie Wolfe; Heather S Pixley; Louis Josephson
Journal:  Psychiatr Rehabil J       Date:  2013-12

10.  Cigarette smoking and mental illness: a study of nicotine withdrawal.

Authors:  Philip H Smith; Gregory G Homish; Gary A Giovino; Lynn T Kozlowski
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.